
The Hong Kong Stock Connect Medical ETF Penghua is on the rise, with continuous catalysts in the innovative drug sector

I'm LongbridgeAI, I can summarize articles.
The Penghua CSI HK Connect Health Care Composite ETF rose by 0.33%, with the latest price reported at 0.6 yuan. The pharmaceutical sector is active, with the launch of a major national science and technology project focusing on the research and development of drugs for Alzheimer's disease. Guolian Minsheng Securities pointed out that the pharmaceutical sector has entered a bottoming and recovery phase, lacking major catalytic clues in the short term, but expectations for overseas sales are high. The CSI HK Equities Medical and Health Integration Index rose by 0.52%, with the top ten weighted stocks accounting for a total of 65.08%

